ARTS II: Arterial Revascularization Therapies Study Part II of the Sirolimus-Eluting Bx VELOCITY Balloon Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions.

Trial Profile

ARTS II: Arterial Revascularization Therapies Study Part II of the Sirolimus-Eluting Bx VELOCITY Balloon Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions.

Completed
Phase of Trial: Phase III

Latest Information Update: 12 May 2009

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms ARTS-II
  • Sponsors Cordis Corporation
  • Most Recent Events

    • 12 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 12 May 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
    • 24 Mar 2009 Planned end date changed from 1 Feb 2009 to 1 Mar 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top